Navigation Links
FDA Approves Seasonal Flu Vaccine for 2009-2010
Date:7/20/2009

Health experts still working on H1N1 swine flu vaccine, which should be ready by fall

MONDAY, July 20 (HealthDay News) -- The U.S. Food and Drug Administration has approved the vaccine to protect against the 2009-2010 seasonal flu, health officials announced Monday.

The agency noted that this vaccine will not protect people from the new H1N1 swine flu that has reached pandemic proportions around the world and is expected to return to the United States in the fall. A separate vaccine to protect against that flu strain is now under development and about to undergo testing. The swine flu vaccine is expected to be available sometime in the fall, according to the FDA.

"The approval of this year's seasonal influenza vaccine is an example of the FDA's important responsibility to assure timely availability of vaccine to help protect the health of the American public," Dr. Margaret A. Hamburg, the FDA's commissioner of food and drugs, said in a prepared statement. "A new seasonal influenza vaccine each year is a critical tool in protecting public health."

This year's vaccine contains:

  • an A/Brisbane/59/2007 (H1N1)-like virus.
  • an A/Brisbane/10/2007 (H3N2)-like virus.
  • a B/Brisbane/60/2008-like virus.

These are the seasonal flu strains most likely to be circulating this year. Anyone who wants to get a vaccination can, according to the U.S. Centers for Disease Control and Prevention. But the shot is particularly recommended for children 6 months up to 19 years old; pregnant women; anyone 50 and older; people with certain chronic medical conditions; people living in nursing homes and other long-term care facilities; and people who live with or care for those at high risk for complications from the flu.

"It's important to have a yearly flu shot," said Dr. Marc Siegel, an associate professor of medicine at New York University Langone Medical Center in New York City. "The problem with the yearly flu shot in kids is you often need a second shot. So if we are talking about an H1N1 shot too, you may need four shots, that's the only issue. But both are important."

People should start getting vaccinated for seasonal flu in September and October, but they can get vaccinated as late as "December, January and beyond," according to the CDC.

No vaccine is 100 percent effective, but it's the best protection against flu and can prevent many illnesses and deaths, the FDA said.

People need to get vaccinated each year because the strains of circulating flu differ each year. Every year, experts from the FDA, the CDC, the World Health Organization and elsewhere collect flu virus samples from around the world to identify strains that may cause the most illness during the upcoming season.

Based on these forecasts and on the recommendations of the FDA's Vaccine and Related Products Advisory Committee, the agency determines the strains that should be included in vaccines for the U.S. population. The closer the match between the strains in the vaccine and those circulating, the better the protection against the flu.

It's possible the match between the vaccine and circulating virus is less than optimal. But even in years when the vaccine isn't a good match, a shot can reduce the severity of the flu if you catch it, and it may help prevent flu-related complications, according to the FDA.

Each year in the United States an estimated 5 percent to 20 percent of the population is stricken with the seasonal flu. More than 200,000 people are hospitalized and about 36,000 people die. Older people, young children, and people with chronic health problems are at higher risk for flu-related complications.

The FDA said the six vaccines for 2009-2010 and the manufacturers are: Afluria, CSL Limited; Fluarix, GlaxoSmithKline Biologicals; FluLaval, ID Biomedical Corporation; Fluvirin, Novartis Vaccines and Diagnostics Limited; Fluzone, Sanofi Pasteur Inc.; and FluMist, MedImmune Vaccines Inc.

More information

To learn more about seasonal flu, visit the U.S. Centers for Disease Control and Prevention.



SOURCES: Marc Siegel, M.D., associate professor of medicine, New York University Langone Medical Center, New York City; July 20, 2009, news release, U.S. Food and Drug Administration; U.S. Centers for Disease Control and Prevention


'/>"/>
Copyright©2009 ScoutNews,LLC.
All rights reserved

Related medicine news :

1. FDA Approves Boston Scientifics TAXUS(R) Liberte(R) Long Stent
2. FDA Approves NovoLog(R) Labeling Update
3. Fitness Management Group, Inc. Approves Sale of the Company
4. Cardinal Health Board of Directors Approves CareFusion Spinoff
5. Video: FDA Approves Hologics Adiana(R) Permanent Contraception System
6. European Medicines Agency (EMEA) Approves Cell Therapeutics, Inc.s September Meeting Request to Discuss OPAXIO(TM) Marketing Authorization Application
7. FDA Approves Multaq(R) for Patients with Atrial Fibrillation or Atrial Flutter
8. FDA Approves Lamictal(R)XR(TM); An Extended-Release Once-Daily, New Generation Treatment for Epilepsy
9. FDA Approves Reclast(R) to Prevent Osteoporosis in Postmenopausal Women With Convenient Less Frequent Dosing
10. FDA Approves SAMSCA(TM) (tolvaptan), the First and Only Oral Vasopressin Antagonist to Treat Patients With Clinically Significant Hypervolemic and Euvolemic Hyponatremia
11. ClearWay Minnesota(SM) Board Approves Four Regional Grants
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/29/2017)... (PRWEB) , ... March 29, 2017 , ... AvePoint ... seventh North American office location in Richmond, Virginia, located at the Riverfront Plaza, 901 ... attended by Lieutenant Governor of Virginia Ralph S. Northam and Mayor of Richmond Levar ...
(Date:3/28/2017)... ... March 28, 2017 , ... A recent Bellwether ... teacher quality, the field must first improve teacher preparation program design. It then ... next” and that decades of input- and outcome-based research has failed to improve ...
(Date:3/28/2017)... ... March 28, 2017 , ... For many women, getting birth control isn’t as easy as it ... either don’t have access to a health care facility or a pharmacy within 60 minutes ... the United States or for many who are faced with health or personal issues that ...
(Date:3/28/2017)... ... March 28, 2017 , ... ... Ruel Williamson brings his extensive knowledge of appraisals, property values, ad valorem taxation, ... real estate valuation industry for more than 40 years. , “Ruel is a ...
(Date:3/28/2017)... ... March 28, 2017 , ... ... state legislatures and Congress to protect parental rights and civil liberties, and to ... in America. , The demonstration coincides with a press conference taking place Friday ...
Breaking Medicine News(10 mins):
(Date:3/29/2017)... -- According to a new market research report "Medical Radiation ... Survey Meter, Solid-State), Products (Personal Dosimeters, OSL, Badges), Safety (Apron, Shields, Face ... market is expected to reach USD 1,215.4 Million by 2021 from USD ... 2021. Continue Reading ... ...
(Date:3/29/2017)... 2017 Research and Markets has announced the ... to their offering. ... The global lifestyle drugs market to grow at a CAGR ... Global Lifestyle Drugs Market 2017-2021, has been prepared based on an ... the market landscape and its growth prospects over the coming years. ...
(Date:3/29/2017)... Mar 29, 2017 Research and Markets has ... Forecast to 2023" report to their offering. ... The ablation device global market ... $20,995.5 million by 2023. Ablation is the minimally ... purposes, from cancerous or diseased tissue removal, to the removal of ...
Breaking Medicine Technology: